İnci Tugce Colluoglu
@tugceinci88
Followers
74
Following
1K
Media
12
Statuses
378
MD, FHFA, https://t.co/zHje6LCvNO., HFA Young ambassador 🇹🇷 (2022-2024)
Karabük, Turkey
Joined August 2021
So… are we overtreating some post-ablation patients with DOACs??🤔
Presented at #AHA25: In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results:
1
1
4
We are delighted to announce the 3rd Eurasian Heart Failure Congress & Global Advanced Heart Failure Symposium, a Joint Meeting bringing together leading experts from around the world. 🗓️ 1–4 October 2026 📍 Swissôtel The Bosphorus, Istanbul #HeartFailure #EurasianHF2026
0
5
8
🗞️ Future development of arrhythmogenic risk scores in patients with #HeartFailure & inherited dilated cardiomyopathy. A scientific statement of the #HFA of @escardio
@ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
@HFA_President
https://t.co/BF7LQEPOrP
2
28
70
Proud to be part of this outstanding consensus project — now published!
Multimodality imaging in advanced heart failure. A clinical consensus statement of the #HFA of the ESC. Part 1: Multimodality imaging for the evaluation of patients with advanced HF https://t.co/6U8Miqjtvl
@ESC_Journals @HanCardiomd @AmrAbdin10 @GiuseppeGalati_
0
4
11
International KOLs at the 2nd Eurasian Heart Failure Congress
0
4
10
🎯 Want to ace your HFA Certification Exam on 31 October 2025? The HFA Certification Exam Prep Course is now live on the new ESC eLearning platform! ✅ Comprehensive heart failure review ✅ Expert-led content ✅ ✅ Practice questions and mock exams ✨ https://t.co/xYxVYofpkF
0
9
13
Bu davete kayıtsız kalınmaz 🙌😀 2. Avrasya Kalp Yetersizliği Kongresi https://t.co/AY79U3XBCg
@HFsocEurasia @temizhan @drheartfailure
0
3
23
Kalp yetmezliği ve ritim bozukluğu olanlara yeni tedavi umudu. 📍🇹🇷 https://t.co/J7RRO8ktW8
aa.com.tr
Türk bilim insanları tarafından yürütülen çalışmada, şeker hastalığı tedavisinde kullanılan bir ilaç grubunun aynı zamanda kalp hastalarında da yeni bir koruyucu rol oynayabileceği ortaya konuldu. -...
0
14
50
🚨 Hot off the press: JACC Advances SGLT2i ↓ myocardial glucose uptake on FDG-PET: ▪️ 374-pt matched cohort ▪️ “No uptake” in 65 % on SGLT2i vs 37 % controls ▪️ Total myocardial glycolysis ⬇️ despite ↑ prescan glucose Metabolic shift may underlie CV benefits & carries
5
66
176
Identifying congestion phenotypes using unsupervised #MachineLearning in acute #HeartFailure
https://t.co/MTT9zpc3RK
#EHJDigital #ArtificialIntelligence
@BruiningNico @rafavidalperez @fwasselbergs @rbcasado @HFA_President
1
25
80
U.S. FDA Approves Finerenone for New Indication in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥ 40% Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved finerenone (Kerendia™), a non-steroidal, selective
1
45
116
Admission Ca-125 to identify diuretic response in hospitalized patient...
0
0
3
Arşiv Dergisi’nin Haziran sayısında yayımlanan “Kılavuzların Ötesinde: Kalp Yetersizliği Olan Hastalarda Mortaliteyi Tahmin Etmede Tip 1 Demir Eksikliğinin Kritik Rolü” başlıklı makaleyi, Dr. Levent Pay, Dr. Tuğçe Çöllüoğlu, Dr. Erdem Çevik ile değerlendirdiğimiz video yayında!
0
4
7
🗞️ Insights into the European #heartfailure epidemiology @ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
https://t.co/cMhkS4nZ53
1
34
61
📢 Just published in @ESCHeartFailure We screened 874 high-risk patients in primary care using NT-proBNP. 🔍 Results: •69.1% Stage A •21.9% Stage B (pre-HF) •9.0% Stage C (symptomatic HF) 🫀 Among Stage C, 92.4% had HFpEF ✅ NT-proBNP helped identify early-stage HF and guide
0
8
24
TSAT-based definition of iron deficiency can be a significant factor in mortality in heart failure. @TKD @HFSoT_TR @HFA_ESC
#HeartFailure #IronDeficiency
0
0
4